Indication

Prevention of radiation therapy-induced mucositis

Prevention of radiation therapy-induced mucositis refers to prophylactic clinical strategies aimed at averting or mitigating acute mucosal injury caused by ionizing radiation, most commonly involving the oral and oropharyngeal tract during treatment for head and neck malignancies. Read more about Prevention of radiation therapy-induced mucositis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Prevention of radiation therapy-induced mucositis therapies.

Showing 1–1 of 1 drugs

KEPIVANCE (palifermin)

TREATMENT INDUCED MUCOSITIS AGENTS·PREVENTION OF CHEMOTHERAPY-INDUCED MUCOSITIS·+1
BIOVITRUM
Filter & compare in the drug finder →Opens the drug finder with Prevention of radiation therapy-induced mucositis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Prevention of radiation therapy-induced mucositis.

Prevention of radiation therapy-induced mucositis refers to prophylactic clinical strategies aimed at averting or mitigating acute mucosal injury caused by ionizing radiation, most commonly involving the oral and oropharyngeal tract during treatment for head and neck malignancies.

The condition arises when therapeutic radiation damages rapidly dividing basal epithelial cells and induces oxidative stress, triggering a biological cascade of pro-inflammatory cytokines, tissue necrosis, and loss of mucosal barrier integrity.

Clinically, it manifests as painful erythema, edema, and deep pseudomembranous ulcerations that can lead to severe dysphagia, dehydration, malnutrition, secondary infections, and unplanned interruptions in oncologic therapy.

Personalize your experience

Follow Prevention of radiation therapy-induced mucositis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it